Home
/

What is a Neutrophil-to-Lymphocyte & Platelet Ratio Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

NLPR is a composite CBC-derived index—typically calculated as neutrophils ÷ (lymphocytes × platelets)—that integrates innate inflammation, adaptive immunity, and platelet-mediated thrombotic signaling into one marker of systemic immune-thrombotic stress. A higher NLPR reflects greater inflammatory and pro-thrombotic activation; it has been studied as a prognostic marker in cancer, cardiovascular events, and sepsis, capturing vascular–immune crosstalk that simpler ratios may miss.

Read more →
Table of contents

NLPR: A Three-Cell Composite From Your CBC

The Neutrophil-to-Lymphocyte & Platelet Ratio (NLPR) is a composite number derived from a standard complete blood count. It combines three cell types that circulate in your blood: neutrophils (innate immune granulocytes), lymphocytes (adaptive immune T and B cells), and platelets (thrombocytes involved in clotting). By drawing on these routinely measured counts, NLPR links where the signal comes from—your bone marrow–produced blood cells—to how your immune and clotting systems are currently behaving.

NLPR's value is in what it summarizes. It captures the body's integrated response to physiological stress and inflammation by reflecting three interconnected pathways at once: front-line inflammatory activity (neutrophils), immune regulation and resilience (lymphocytes), and clotting/inflammatory crosstalk (platelets). This makes NLPR a practical, single-readout view of systemic inflammation and "thromboinflammation," offering a compact picture of how activated, suppressed, or balanced these systems are at a given moment. Clinically and in research, it serves as a general index of inflammatory burden and stress physiology across diverse conditions, without needing additional specialized testing.

Why Three Cell Lines Reveal Thromboinflammation

The neutrophil-to-lymphocyte & platelet ratio (NLPR) is a composite signal of how your innate immunity (neutrophils), adaptive immunity (lymphocytes), and clotting system (platelets) are behaving together. When these three systems are in balance, the body handles infections, heals tissue, and keeps blood flow smooth; when the balance shifts, it often reflects whole-body inflammation and stress.

At a systems level, it reflects the body's inflammatory load and clotting readiness, linking to cardiometabolic risk, vascular health, recovery from illness, and overall resilience.

Reading an NLPR From Low to High

There is no universal reference range because NLPR is calculated differently across studies and labs. Broadly, healthier states cluster toward the lower end of a lab's interval, and rising values generally track with stronger systemic inflammation and illness severity.

When this index is on the lower side, it can simply represent a calm inflammatory tone with adequate lymphocyte and platelet reserves. Very low values may also reflect bone-marrow suppression or specific cytopenias—neutropenia raising infection risk (fevers, mouth sores) or thrombocytopenia increasing bruising and bleeding. Children often run lower because they have relatively higher lymphocyte counts; during pregnancy, mild platelet lowering can shift the ratio, so context matters.

Low values usually reflect either a lymphocyte-predominant, low-inflammation state or low neutrophils/platelets from bone marrow suppression, viral illness, autoimmune destruction, or certain medications. Physiologically low suggests efficient adaptive immunity and lower inflammatory burden; pathologically low can signal higher infection or bleeding risk.

Being in range suggests balanced innate and adaptive immune activity with platelets supporting normal hemostasis. This pattern aligns with stable energy use, endothelial health, and a low, well-regulated inflammatory set point. Most outcome studies show risk rises as the ratio increases within normal, so "within reference ranges" tends to be toward the lower end of the reference range.

Higher values usually indicate neutrophil-predominant inflammation with relative lymphocyte suppression and platelet activation/consumption—seen in acute infections, trauma, flares of chronic disease, and advanced atherosclerosis. People may notice fever, fatigue, brain fog, rapid heart rate, or clotting tendencies; in severe cases (sepsis, advanced cancer), very high values correlate with organ strain and worse outcomes. Late pregnancy can nudge the index upward due to physiologic neutrophilia.

High values usually reflect neutrophil-driven inflammation, relative lymphopenia, and platelet activation, as seen with acute infection, tissue injury, physiologic/psychological stress, chronic cardiometabolic inflammation, smoking, or glucocorticoids. System effects include higher oxidative stress, insulin resistance, endothelial activation, and a prothrombotic milieu. Values often trend higher with aging and during pregnancy.

Acute Factors and Medications That Shift NLPR

Interpretation depends on context. Acute illness, surgery, strenuous exercise, pregnancy, age, corticosteroids, beta-agonists, and myelosuppressive therapies can shift counts. Calculation methods and reference ranges vary across labs, and values fluctuate diurnally; comparison over time is most informative once acute factors resolve.

What NLPR Adds Beyond NLR or PLR

Big picture: NLPR connects immune tone to vascular and coagulation biology, and it often moves with cortisol surges, metabolic stress, and chronic inflammatory load. Used alongside clinical context and related markers (CRP, ferritin, D-dimer, NLR/PLR), it helps frame current inflammatory burden and long-term risk.

FAQs

NLPR testing calculates a composite index using absolute neutrophils, absolute lymphocytes, and platelets from a standard complete blood count (CBC) to reflect inflammatory and thrombo-immune balance.

NLPR helps track systemic inflammatory load and complements markers such as CRP and ESR, offering insight into recovery, training stress, and illness trends.

Establish a baseline when well, then retest with significant illness or recovery, or at a chosen cadence (for example, every 3–6 months) to monitor trends.

Acute infections, training load, sleep loss, psychological stress, smoking, medications (e.g., corticosteroids, immunosuppressants), iron status, and hydration can shift neutrophils, lymphocytes, or platelets, altering NLPR.

No special preparation is typically needed for a CBC with differential and platelet count. Staying well hydrated can support sample quality.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024). Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turkish Journal of Emergency Medicine, 24(1), 8-19. https://doi.org/10.4103/tjem.tjem_198_23
  2. Guo, W., Lu, X., Liu, Q., Zhang, T., Li, P., Qiao, W., & Deng, M. (2019). Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Medicine, 8(9), 4135-4148. https://doi.org/10.1002/cam4.2281
  3. Huang, Z., Fu, Z., Huang, W., & Huang, K. (2020). Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. The American Journal of Emergency Medicine, 38(3), 641-647. https://doi.org/10.1016/j.ajem.2019.10.023
  4. Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022). Beyond hemostasis: Platelet innate immune interactions and thromboinflammation. International Journal of Molecular Sciences, 23(7), 3868. https://doi.org/10.3390/ijms23073868
  5. Ye, Z., Hu, T., Wang, J., Xiao, R., Liao, X., Liu, M., & Sun, Z. (2022). Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 9, 933913. https://doi.org/10.3389/fcvm.2022.933913
  6. Buonacera, A., Stancanelli, B., Colaci, M., & Malatino, L. (2022). Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the immune system and diseases. International Journal of Molecular Sciences, 23(7), 3636. https://doi.org/10.3390/ijms23073636

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey